{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T13:28:05Z","timestamp":1745501285069,"version":"3.37.3"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1136829","1156072"],"award-info":[{"award-number":["1136829","1156072"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001778","name":"Deakin University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001778","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Novel approaches are required to find new treatments for schizophrenia and other neuropsychiatric disorders. This study utilised a combination of in vitro transcriptomics and in silico analysis with the BROAD Institute\u2019s Connectivity Map to identify drugs that can be repurposed to treat psychiatric disorders. Human neuronal (NT2-N) cells were treated with a combination of atypical antipsychotic drugs commonly used to treat psychiatric disorders (such as schizophrenia, bipolar disorder, and major depressive disorder), and differential gene expression was analysed. Biological pathways with an increased gene expression included circadian rhythm and vascular endothelial growth factor signalling, while the adherens junction and cell cycle pathways were transcriptionally downregulated. The Connectivity Map (CMap) analysis screen highlighted drugs that affect global gene expression in a similar manner to these psychiatric disorder treatments, including several other antipsychotic drugs, confirming the utility of this approach. The CMap screen specifically identified metergoline, an ergot alkaloid currently used to treat seasonal affective disorder, as a drug of interest. In mice, metergoline dose-dependently reduced MK-801- or methamphetamine-induced locomotor hyperactivity confirming the potential of metergoline to treat positive symptoms of schizophrenia in an animal model. Metergoline had no effects on prepulse inhibition deficits induced by MK-801 or methamphetamine. Taken together, metergoline appears a promising drug for further studies to be repurposed as a treatment for schizophrenia and possibly other psychiatric disorders.<\/jats:p>","DOI":"10.1007\/s12640-023-00673-0","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T06:01:46Z","timestamp":1698991306000},"page":"502-513","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Metergoline Shares Properties with Atypical Antipsychotic Drugs Identified by Gene Expression Signature Screen"],"prefix":"10.1007","volume":"41","author":[{"given":"Chiara C","family":"Bortolasci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily J","family":"Jaehne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dami\u00e1n","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Briana","family":"Spolding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruna","family":"Panizzutti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia M","family":"Dean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamsyn M","family":"Crowley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison R","family":"Yung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Gray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jee Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten","family":"van den Buuse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Berk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Walder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,3]]},"reference":[{"key":"673_CR1","doi-asserted-by":"publisher","unstructured":"Adell A (2020) Brain NMDA receptors in schizophrenia and depression. Biomolecules 10(6):947.\u00a0Available from: https:\/\/doi.org\/10.3390\/biom10060947","DOI":"10.3390\/biom10060947"},{"issue":"20","key":"673_CR2","doi-asserted-by":"publisher","first-page":"8394","DOI":"10.1523\/JNEUROSCI.18-20-08394.1998","volume":"18","author":"VP Bakshi","year":"1998","unstructured":"Bakshi VP, Geyer MA (1998) Multiple limbic regions mediate the disruption of prepulse inhibition produced in rats by the noncompetitive NMDA antagonist dizocilpine. J Neurosci 18(20):8394\u2013401","journal-title":"J Neurosci"},{"issue":"7\u20138","key":"673_CR3","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.neuropharm.2010.12.011","volume":"60","author":"FM Benes","year":"2011","unstructured":"Benes FM (2011) Regulation of cell cycle and DNA repair in post-mitotic GABA neurons in psychotic disorders. Neuropharmacology 60(7\u20138):1232\u201342","journal-title":"Neuropharmacology"},{"issue":"10","key":"673_CR4","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1176\/ajp.156.10.1635","volume":"156","author":"IZ Ben-Zion","year":"1999","unstructured":"Ben-Zion IZ, Meiri G, Greenberg BD, Murphy DL, Benjamin J (1999) Enhancement of CO2-induced anxiety in healthy volunteers with the serotonin antagonist metergoline. Am J Psychiatry 156(10):1635\u20137","journal-title":"Am J Psychiatry"},{"issue":"5","key":"673_CR5","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1176\/appi.ajp.2014.14070858","volume":"172","author":"M Berk","year":"2015","unstructured":"Berk M, Nierenberg AA (2015) Three paths to drug discovery in psychiatry. Am J Psychiatry 172(5):412\u20134","journal-title":"Am J Psychiatry"},{"issue":"2","key":"673_CR6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/schbul\/19.2.233","volume":"19","author":"DL Braff","year":"1993","unstructured":"Braff DL (1993) Information processing and attention dysfunctions in schizophrenia. Schizophr Bull 19(2):233\u201359","journal-title":"Schizophr Bull"},{"issue":"4","key":"673_CR7","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1111\/j.1476-5381.1993.tb14010.x","volume":"110","author":"SC Cheetham","year":"1993","unstructured":"Cheetham SC, Heal DJ (1993) Evidence that RU 24969-induced locomotor activity in C57\/B1\/6 mice is specifically mediated by the 5-HT1B receptor. Br J Pharmacol 110(4):1621\u20139","journal-title":"Br J Pharmacol"},{"issue":"11","key":"673_CR8","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/jhg.2009.93","volume":"54","author":"TT Chu","year":"2009","unstructured":"Chu TT, Liu Y, Kemether E (2009) Thalamic transcriptome screening in three psychiatric states. J Hum Genet 54(11):665\u201375","journal-title":"J Hum Genet"},{"issue":"9916","key":"673_CR9","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0140-6736(13)62106-6","volume":"383","author":"J Cummings","year":"2014","unstructured":"Cummings J, Isaacson S, Mills R, Williams H, Chi-Burris K, Corbett A et al (2014) Pimavanserin for patients with Parkinson\u2019s disease psychosis: a randomised, placebo-controlled phase 3 trial. Lancet 383(9916):533\u201340","journal-title":"Lancet"},{"key":"673_CR10","doi-asserted-by":"publisher","unstructured":"Dall\u00e9rac G, Li X, Lecouflet P, Morisot N, Sacchi S, Asselot R, ... Mothet JP (2021) Dopaminergic neuromodulation of prefrontal cortex activity requires the NMDA receptor coagonist d-serine.\u00a0Proc Natl Acad Sci USA\u00a0118(23).\u00a0Available from: https:\/\/doi.org\/10.1073\/pnas.2023750118","DOI":"10.1073\/pnas.2023750118"},{"key":"673_CR11","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.bbi.2018.05.002","volume":"71","author":"D Frydecka","year":"2018","unstructured":"Frydecka D, Krzystek-Korpacka M, Lubeiro A, Stramecki F, Sta\u0144czykiewicz B, Besz\u0142ej JA et al (2018) Profiling inflammatory signatures of schizophrenia: a cross-sectional and meta-analysis study. Brain Behav Immun 71:28\u201336","journal-title":"Brain Behav Immun"},{"issue":"3","key":"673_CR12","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.psychres.2014.06.039","volume":"219","author":"A Ghanizadeh","year":"2014","unstructured":"Ghanizadeh A, Rezaee Z, Dehbozorgi S, Berk M, Akhondzadeh S (2014) Lovastatin for the adjunctive treatment of schizophrenia: a preliminary randomized double-blind placebo-controlled trial. Psychiatry Res 219(3):431\u20135","journal-title":"Psychiatry Res"},{"issue":"6","key":"673_CR13","doi-asserted-by":"publisher","first-page":"R740","DOI":"10.1152\/ajpregu.00602.2011","volume":"302","author":"JD Glass","year":"2012","unstructured":"Glass JD, Brager AJ, Stowie AC, Prosser RA (2012) Cocaine modulates pathways for photic and nonphotic entrainment of the mammalian SCN circadian clock. Am J Physiol Regul Integr Comp Physiol 302(6):R740-50","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"Suppl 2","key":"673_CR14","doi-asserted-by":"publisher","first-page":"S132","DOI":"10.1590\/1516-4446-2013-1164","volume":"35","author":"PH Gobira","year":"2013","unstructured":"Gobira PH, Ropke J, Aguiar DC, Crippa JA, Moreira FA (2013) Animal models for predicting the efficacy and side effects of antipsychotic drugs. Braz J Psychiatry 35(Suppl 2):S132-9","journal-title":"Braz J Psychiatry"},{"issue":"5\u20136","key":"673_CR15","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1097\/FBP.0b013e32830cd822","volume":"19","author":"A Gogos","year":"2008","unstructured":"Gogos A, Bogeski M, van den Buuse M (2008) Role of serotonin-1A receptors in the action of antipsychotic drugs: comparison of prepulse inhibition studies in mice and rats and relevance for human pharmacology. Behav Pharmacol 19(5\u20136):548\u201361","journal-title":"Behav Pharmacol"},{"key":"673_CR16","doi-asserted-by":"crossref","unstructured":"Gogos A, Kusljic S, van den Buuse M (2005) 8-OH-DPAT-induced effects on prepulse inhibition: pre- vs. post-synaptic 5-HT1A receptor activation. Pharmacol Biochem Behav 81(3):664\u201372","DOI":"10.1016\/j.pbb.2005.05.007"},{"key":"673_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0074-7742(06)78001-1","volume":"78","author":"O Guillin","year":"2007","unstructured":"Guillin O, Abi-Dargham A, Laruelle M (2007) Neurobiology of dopamine in schizophrenia. Int Rev Neurobiol 78:1\u201339","journal-title":"Int Rev Neurobiol"},{"issue":"4","key":"673_CR18","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2174\/1389201019666180620112528","volume":"19","author":"M Haaf","year":"2018","unstructured":"Haaf M, Leicht G, Curic S, Mulert C (2018) Glutamatergic deficits in schizophrenia - biomarkers and pharmacological interventions within the ketamine model. Curr Pharm Biotechnol 19(4):293\u2013307","journal-title":"Curr Pharm Biotechnol"},{"key":"673_CR19","doi-asserted-by":"publisher","unstructured":"Hawi Z, Tong J, Dark C, Yates H, Johnson B, Bellgrove MA (2018) The role of cadherin genes in five major psychiatric disorders: a literature update [Internet]. Vol. 177,\u00a0Am J Med Genet B Neuropsychiatr Genet\u00a0168\u201380. Available from: https:\/\/doi.org\/10.1002\/ajmg.b.32592","DOI":"10.1002\/ajmg.b.32592"},{"issue":"856","key":"673_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2019.05.031","volume":"5","author":"N Hendouei","year":"2019","unstructured":"Hendouei N, Saghafi F, Shadfar F, Hosseinimehr SJ (2019) Molecular mechanisms of anti-psychotic drugs for improvement of cancer treatment. Eur J Pharmacol 5(856):172402","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"673_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1177\/0269881114563634","volume":"29","author":"O Howes","year":"2015","unstructured":"Howes O, McCutcheon R, Stone J (2015) Glutamate and dopamine in schizophrenia: an update for the 21st century. J Psychopharmacol 29(2):97\u2013115","journal-title":"J Psychopharmacol"},{"issue":"5","key":"673_CR22","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.pharep.2018.05.005","volume":"70","author":"M J\u00f3\u017awiak-B\u0119benista","year":"2018","unstructured":"J\u00f3\u017awiak-B\u0119benista M, Jasi\u0144ska-Stroschein M, Kowalczyk E (2018) Involvement of vascular endothelial growth factor (VEGF) and mitogen-activated protein kinases (MAPK) in the mechanism of neuroleptic drugs. Pharmacol Rep 70(5):1032\u20139","journal-title":"Pharmacol Rep"},{"key":"673_CR23","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1111\/j.1476-5381.2011.01386.x","volume":"164","author":"CA Jones","year":"2011","unstructured":"Jones CA, Watson DJG, Fone KCF (2011) Animal models of schizophrenia. Br J Pharmacol 164:1162\u20131194","journal-title":"Br J Pharmacol"},{"issue":"3\u20134","key":"673_CR24","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.brainresbull.2010.04.006","volume":"83","author":"JT Kantrowitz","year":"2010","unstructured":"Kantrowitz JT, Javitt DC (2010) N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia? Brain Res Bull 83(3\u20134):108\u201321","journal-title":"Brain Res Bull"},{"issue":"10","key":"673_CR25","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1080\/15622975.2018.1492734","volume":"21","author":"S Kidnapillai","year":"2020","unstructured":"Kidnapillai S, Bortolasci CC, Udawela M, Panizzutti B, Spolding B, Connor T et al (2020) The use of a gene expression signature and connectivity map to repurpose drugs for bipolar disorder. World J Biol Psychiatry 21(10):775\u201383","journal-title":"World J Biol Psychiatry"},{"issue":"4","key":"673_CR26","doi-asserted-by":"publisher","first-page":"R36","DOI":"10.1186\/gb-2013-14-4-r36","volume":"14","author":"D Kim","year":"2013","unstructured":"Kim D, Pertea G, Trapnell C, Pimentel H, Kelley R, Salzberg SL (2013) TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol 14(4):R36","journal-title":"Genome Biol"},{"issue":"8","key":"673_CR27","doi-asserted-by":"publisher","first-page":"725","DOI":"10.30773\/pi.2020.0129","volume":"17","author":"SS Kirlioglu","year":"2020","unstructured":"Kirlioglu SS, Balcioglu YH (2020) Chronobiology revisited in psychiatric disorders: from a translational perspective. Psychiatry Investig 17(8):725\u201343","journal-title":"Psychiatry Investig"},{"issue":"3","key":"673_CR28","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.tcb.2005.01.004","volume":"15","author":"KS Kosik","year":"2005","unstructured":"Kosik KS, Donahue CP, Israely I, Liu X, Ochiishi T (2005) Delta-catenin at the synaptic-adherens junction. Trends Cell Biol 15(3):172\u20138","journal-title":"Trends Cell Biol"},{"issue":"5","key":"673_CR29","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1007\/s00213-020-05467-2","volume":"237","author":"AK Kraeuter","year":"2020","unstructured":"Kraeuter AK, Mashavave T, Suvarna A, van den Buuse M, Sarnyai Z (2020) Effects of beta-hydroxybutyrate administration on MK-801-induced schizophrenia-like behaviour in mice. Psychopharmacology 237(5):1397\u2013405","journal-title":"Psychopharmacology"},{"key":"673_CR30","doi-asserted-by":"publisher","unstructured":"Kulkarni J, Gavrilidis E, Gwini SM, Worsley R, Grigg J, Warren A et al (2016) Effect of adjunctive raloxifene therapy on severity of refractory schizophrenia in women [Internet]. Vol. 73., JAMA Psychiatry 947. Available from: https:\/\/doi.org\/10.1001\/jamapsychiatry.2016.1383","DOI":"10.1001\/jamapsychiatry.2016.1383"},{"issue":"5795","key":"673_CR31","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1126\/science.1132939","volume":"313","author":"J Lamb","year":"2006","unstructured":"Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ et al (2006) The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313(5795):1929\u201335","journal-title":"Science"},{"key":"673_CR32","doi-asserted-by":"crossref","unstructured":"Laruelle M, Frankle WG, Narendran R, Kegeles LS, Abi-Dargham A (2005) Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitation. Clin Ther 27 Suppl A:S16\u201324","DOI":"10.1016\/j.clinthera.2005.07.017"},{"issue":"10","key":"673_CR33","doi-asserted-by":"publisher","first-page":"7056","DOI":"10.1007\/s12035-019-1578-2","volume":"56","author":"M Maes","year":"2019","unstructured":"Maes M, Sirivichayakul S, Kanchanatawan B, Vodjani A (2019) Upregulation of the intestinal paracellular pathway with breakdown of tight and adherens junctions in deficit schizophrenia. Mol Neurobiol 56(10):7056\u201373","journal-title":"Mol Neurobiol"},{"key":"673_CR34","doi-asserted-by":"publisher","unstructured":"Maes M, Vojdani A, Sirivichayakul S, Barbosa D, Kanchanatawan B (2021) Inflammatory and oxidative pathways are new drug targets in multiple episode schizophrenia and leaky gut, Klebsiella pneumoniae, and C1q immune complexes are additional drug targets in first episode schizophrenia [Internet]. Available from: https:\/\/doi.org\/10.20944\/preprints202012.0457.v1","DOI":"10.20944\/preprints202012.0457.v1"},{"issue":"7","key":"673_CR35","first-page":"92","volume":"12","author":"EE Manning","year":"2013","unstructured":"Manning EE, van den Buuse M (2013) BDNF deficiency and young-adult methamphetamine induce sex-specific effects on prepulse inhibition regulation. Front Cell Neurosci 12(7):92","journal-title":"Front Cell Neurosci"},{"issue":"14","key":"673_CR36","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1097\/WNR.0b013e3282e9a863","volume":"18","author":"D Mohr","year":"2007","unstructured":"Mohr D, Pilz PKD, Plappert CF, Fendt M (2007) Accumbal dopamine D2 receptors are important for sensorimotor gating in C3H mice. Neuroreport 18(14):1493\u20137","journal-title":"Neuroreport"},{"issue":"108","key":"673_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2020.110162","volume":"8","author":"E Moon","year":"2021","unstructured":"Moon E, Lavin P, Storch KF, Linnaranta O (2021) Effects of antipsychotics on circadian rhythms in humans: a systematic review and meta-analysis. Prog Neuropsychopharmacol Biol Psychiatry 8(108):110162","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"4","key":"673_CR38","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/BF00439556","volume":"97","author":"KP Nanry","year":"1989","unstructured":"Nanry KP, Tilson HA (1989) The role of 5HT1A receptors in the modulation of the acoustic startle reflex in rats. Psychopharmacology 97(4):507\u201313","journal-title":"Psychopharmacology"},{"issue":"4","key":"673_CR39","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.pharep.2018.01.009","volume":"70","author":"A Nikiforuk","year":"2018","unstructured":"Nikiforuk A (2018) Assessment of cognitive functions in animal models of schizophrenia. Pharmacol Rep 70(4):639\u2013649","journal-title":"Pharmacol Rep"},{"issue":"3","key":"673_CR40","first-page":"665","volume":"43","author":"MJ Notaras","year":"2017","unstructured":"Notaras MJ, Hill RA, Gogos JA, van den Buuse M (2017) BDNF Val66Met genotype interacts with a history of simulated stress exposure to regulate sensorimotor gating and startle reactivity. Schizophr Bull 43(3):665\u201372","journal-title":"Schizophr Bull"},{"issue":"11","key":"673_CR41","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/j.2042-7158.1987.tb03129.x","volume":"39","author":"S Pellow","year":"1987","unstructured":"Pellow S, Johnston AL, File SE (1987) Selective agonists and antagonists for 5-hydroxytryptamine receptor subtypes, and interactions with yohimbine and FG 7142 using the elevated plus-maze test in the rat. J Pharm Pharmacol 39(11):917\u201328","journal-title":"J Pharm Pharmacol"},{"key":"673_CR42","doi-asserted-by":"publisher","unstructured":"Pjrek E, Winkler D, Kasper S (2005) Pharmacotherapy of seasonal affective disorder [Internet]. Vol. 10, CNS Spectrums 664\u20139. Available from: https:\/\/doi.org\/10.1017\/s1092852900019623","DOI":"10.1017\/s1092852900019623"},{"issue":"5","key":"673_CR43","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1523\/JNEUROSCI.12-05-01802.1992","volume":"12","author":"SJ Pleasure","year":"1992","unstructured":"Pleasure SJ, Page C, Lee VM (1992) Pure, postmitotic, polarized human neurons derived from NTera 2 cells provide a system for expressing exogenous proteins in terminally differentiated neurons. J Neurosci 12(5):1802\u201315","journal-title":"J Neurosci"},{"key":"673_CR44","doi-asserted-by":"crossref","unstructured":"Pontiroli AE, Alberetto M, Pellicciotta G, De Castro e Silva E, De Pasqua A, Girardi AM et al (1980) Interaction of dopaminergic and antiserotoninergic drugs in the control of prolactin and LH release in normal women. Acta Endocrinol 93(3):271\u20136","DOI":"10.1530\/acta.0.0930271"},{"key":"673_CR45","doi-asserted-by":"publisher","unstructured":"Powell SB, Zhou X, Geyer MA (2009) Prepulse inhibition and genetic mouse models of schizophrenia [Internet]. Vol. 204, Behav Brain Res 282\u201394. Available from: https:\/\/doi.org\/10.1016\/j.bbr.2009.04.021","DOI":"10.1016\/j.bbr.2009.04.021"},{"issue":"1","key":"673_CR46","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/sj.npp.1300017","volume":"28","author":"RJ Ralph-Williams","year":"2003","unstructured":"Ralph-Williams RJ, Lehmann-Masten V, Geyer MA (2003) Dopamine D1 rather than D2 receptor agonists disrupt prepulse inhibition of startle in mice. Neuropsychopharmacology 28(1):108\u201318","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"673_CR47","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK (2010) edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26(1):139\u201340","journal-title":"Bioinformatics"},{"issue":"11","key":"673_CR48","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1176\/appi.ajp.159.11.1876","volume":"159","author":"CA Roca","year":"2002","unstructured":"Roca CA, Schmidt PJ, Smith MJ, Danaceau MA, Murphy DL, Rubinow DR (2002) Effects of metergoline on symptoms in women with premenstrual dysphoric disorder. Am J Psychiatry 159(11):1876\u201381","journal-title":"Am J Psychiatry"},{"issue":"3","key":"673_CR49","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1192\/bjp.bp.109.067710","volume":"197","author":"SP Singh","year":"2010","unstructured":"Singh SP, Singh V, Kar N, Chan K (2010) Efficacy of antidepressants in treating the negative symptoms of chronic schizophrenia: meta-analysis. Br J Psychiatry 197(3):174\u20139","journal-title":"Br J Psychiatry"},{"key":"673_CR50","doi-asserted-by":"publisher","unstructured":"Turner EH, Schwartz PJ, Lowe CH, Nawab SS, Feldman-Naim S, Drake CL et al (2002) Double-blind, placebo-controlled study of single-dose metergoline in depressed patients with seasonal affective disorder [Internet]. Vol. 22. J Clin Psychopharm 216\u201320. Available from: https:\/\/doi.org\/10.1097\/00004714-200204000-00018","DOI":"10.1097\/00004714-200204000-00018"},{"issue":"22","key":"673_CR51","doi-asserted-by":"publisher","first-page":"5131","DOI":"10.1523\/JNEUROSCI.1021-04.2004","volume":"24","author":"KY Tseng","year":"2004","unstructured":"Tseng KY, O\u2019Donnell P (2004) Dopamine-glutamate interactions controlling prefrontal cortical pyramidal cell excitability involve multiple signaling mechanisms. J Neurosci 24(22):5131\u20139","journal-title":"J Neurosci"},{"issue":"2","key":"673_CR52","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1093\/schbul\/sbp132","volume":"36","author":"M van den Buuse","year":"2010","unstructured":"van den Buuse M (2010) Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects. Schizophr Bull 36(2):246\u201370","journal-title":"Schizophr Bull"},{"issue":"2","key":"673_CR53","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0014-2999(95)00660-5","volume":"287","author":"GB Varty","year":"1995","unstructured":"Varty GB, Higgins GA (1995) Reversal of dizocilpine-induced disruption of prepulse inhibition of an acoustic startle response by the 5-HT2 receptor antagonist ketanserin. Eur J Pharmacol 287(2):201\u20135","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"673_CR54","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/BF02245815","volume":"120","author":"FJ Wan","year":"1995","unstructured":"Wan FJ, Geyer MA, Swerdlow NR (1995) Presynaptic dopamine-glutamate interactions in the nucleus accumbens regulate sensorimotor gating. Psychopharmacology 120(4):433\u201341","journal-title":"Psychopharmacology"},{"key":"673_CR55","unstructured":"World Health Organization (2006) Neurological Disorders: Public Health Challenges. World Health Organization 218"},{"key":"673_CR56","doi-asserted-by":"crossref","unstructured":"Yeom HD, Lee JH (2016) Regulation of human Kv1.4 channel activity by the antidepressant metergoline. Biol Pharm Bull 39(6):1069\u201372","DOI":"10.1248\/bpb.b16-00069"},{"key":"673_CR57","doi-asserted-by":"publisher","unstructured":"Yoon KJ, Nguyen HN, Ursini G, Zhang F, Kim NS, Wen Z et al (2014) Modeling a genetic risk for schizophrenia in iPSCs and mice reveals neural stem cell deficits associated with adherens junctions and polarity [Internet]. Cell Stem Cell 15;79\u201391. Available from: https:\/\/doi.org\/10.1016\/j.stem.2014.05.003","DOI":"10.1016\/j.stem.2014.05.003"},{"key":"673_CR58","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jpsychires.2013.11.014","volume":"50","author":"H Yu","year":"2014","unstructured":"Yu H, Bi W, Liu C, Zhao Y, Zhang JF, Zhang D et al (2014) Protein-interaction-network-based analysis for genome-wide association analysis of schizophrenia in Han Chinese population. J Psychiatr Res 50:73\u20138","journal-title":"J Psychiatr Res"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-023-00673-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12640-023-00673-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-023-00673-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T13:26:13Z","timestamp":1701177973000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12640-023-00673-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,3]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["673"],"URL":"https:\/\/doi.org\/10.1007\/s12640-023-00673-0","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"type":"print","value":"1029-8428"},{"type":"electronic","value":"1476-3524"}],"subject":[],"published":{"date-parts":[[2023,11,3]]},"assertion":[{"value":"26 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Housing conditions and experimental procedures were carried out following the Australian code for the care and use of animals for scientific purposes from the Australian Government National Health and Medical Research Council which complies with The ARRIVE guidelines (Animal Research: Reporting of In Vivo Experiments).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interest"}}]}}